BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10919884)

  • 1. Uveal melanoma: a rare malignancy.
    Gragoudas ES; Egan KM
    Ophthalmology; 2000 Aug; 107(8):1441-2. PubMed ID: 10919884
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited commentary. Uveal melanoma: implications of tumor doubling time.
    O'Brien J
    Ophthalmology; 2001 May; 108(5):831-2. PubMed ID: 11780648
    [No Abstract]   [Full Text] [Related]  

  • 3. Uveal melanoma: implications of tumor doubling time.
    Singh AD
    Ophthalmology; 2001 May; 108(5):829-31. PubMed ID: 11319992
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
    Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE
    Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.
    Eskelin S; Pyrhönen S; Summanen P; Hahka-Kemppinen M; Kivelä T
    Ophthalmology; 2000 Aug; 107(8):1443-9. PubMed ID: 10919885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term progression-free survival in metastatic uveal melanoma after chemoimmunotherapy and consolidation thermoablation.
    Al-Jamal RT; Eskelin S; Pyrhönen S; Kivelä T
    Acta Oncol; 2009; 48(3):476-9. PubMed ID: 19031163
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2018 Sep; 136(9):981-986. PubMed ID: 29955797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in a patient with uveal melanoma and liver metastasis.
    Duh EJ; Schachat AP; Albert DM; Patel SM
    Arch Ophthalmol; 2004 Feb; 122(2):285-7. PubMed ID: 14769612
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.
    Kodjikian L; Grange JD; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):622-4. PubMed ID: 15650857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
    Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
    JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival.
    Vogl T; Eichler K; Zangos S; Herzog C; Hammerstingl R; Balzer J; Gholami A
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):177-84. PubMed ID: 17021903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Trans Am Ophthalmol Soc; 2008; 106():128-35; discussion 135-7. PubMed ID: 19277228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of treatments for metastatic uveal melanoma.
    Augsburger JJ; Corrêa ZM; Shaikh AH
    Am J Ophthalmol; 2009 Jul; 148(1):119-27. PubMed ID: 19375060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of liver directed therapy for uveal melanoma hepatic metastases.
    Rowcroft A; Loveday BPT; Thomson BNJ; Banting S; Knowles B
    HPB (Oxford); 2020 Apr; 22(4):497-505. PubMed ID: 31791894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed systemic recurrence of uveal melanoma.
    Kolandjian NA; Wei C; Patel SP; Richard JL; Dett T; Papadopoulos NE; Bedikian AY
    Am J Clin Oncol; 2013 Oct; 36(5):443-9. PubMed ID: 22706174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after primary enucleation of largest uveal melanomas.
    Gambrelle J; Kodjikian L; Grange JD
    Acta Ophthalmol Scand; 2005 Jun; 83(3):398; 398-9. PubMed ID: 15948802
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival of patients with metastases from uveal melanoma.
    Gragoudas ES; Egan KM; Seddon JM; Glynn RJ; Walsh SM; Finn SM; Munzenrider JE; Spar MD
    Ophthalmology; 1991 Mar; 98(3):383-9; discussion 390. PubMed ID: 2023760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional management of hepatic metastasis from primary uveal melanoma.
    Sato T
    Semin Oncol; 2010 Apr; 37(2):127-38. PubMed ID: 20494705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.